Crunch time for peer review in lawsuit.
Wadman
Meredith
M
D000068579:Celecoxib; D003219:Confidentiality / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000494:pharmacology; D017712:Peer Review, Research / Q000331:legislation & jurisprudence*; D010506:Periodicals as Topic / Q000331:legislation & jurisprudence*; D011720:Pyrazoles / Q000009:adverse effects / Q000494:pharmacology; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology; D014481:United States; D000096926:Benzenesulfonamides
D000068579:Celecoxib; D007555:Isoxazoles; D011720:Pyrazoles; D013449:Sulfonamides; C406224:valdecoxib; D000096926:Benzenesulfonamides